Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 33 of 33 entries
View as:

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04347915 Org: User:
Start: 05/26/20 End: 02/26/21 Due: 02/26/22

Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group

Phase: N/A Priority: Normal
NCT ID: NCT00313261 Org: User:
Start: 06/30/03 End: 02/28/05 Due: 02/28/06

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04891302 Org: User:
Start: 03/19/21 End: 07/08/21 Due: 07/08/22

Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials

Phase: N/A Priority: Normal
NCT ID: NCT00362505 Org: User:
Start: 06/30/04 End: 03/31/06 Due: 03/31/07

Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus

Phase: N/A Priority: Normal
NCT ID: NCT00305019 Org: User:
Start: 07/31/02 End: 03/31/04 Due: 03/31/05

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

Phase: N/A Priority: Normal
NCT ID: NCT00362635 Org: User:
Start: 08/31/06 End: - Due: -

Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV

Phase: N/A Priority: Normal
NCT ID: NCT00501124 Org: User:
Start: 05/31/07 End: - Due: -

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01264354 Org: User:
Start: 03/31/10 End: 02/28/13 Due: 02/28/14